venous sampling in endocrine dx
TRANSCRIPT
-
8/22/2019 Venous Sampling in Endocrine Dx
1/22
VENOUS SAMPLING IN
ENDOCRINE DISEASE
Dr. A. O. AdeyinkaConsultant Radiologist UCH Ibadan
Radiology-Endocrine Update Course
18th September 2012
LUTH Lagos
-
8/22/2019 Venous Sampling in Endocrine Dx
2/22
What is Venous Sampling
Sensitive physiological investigation for
functional localization of hormonal
hyper-secretion
Direct assessment of hormonal
secretions in blood samples taken from
relevant Venous circulations (IVC,
Hepatic Veins, Adrenal Veins)
-
8/22/2019 Venous Sampling in Endocrine Dx
3/22
Objectives of Venous Sampling
To evaluate hormonal secretionabnormalities in endocrine disorders
Aids Differential diagnosis or Sub-type ofabnormal hormonal secretions
Applied to address individual clinicalproblems in coordination with other imagingmodalities
May achieve regional localization orlateralization of the endocrine tumors
Guides therapeutic Management
-
8/22/2019 Venous Sampling in Endocrine Dx
4/22
Types ofEndocrine Venous
Sampling Inferior petrosal sinus sampling
Selective parathyroid venous sampling
Hepatic venous sampling with arterial
stimulation
Adrenal venous sampling
Ovarian venous sampling.
Pancreatic Venous Sampling with Arterial
stimulation
(mmnemonic: HIPOPA)
-
8/22/2019 Venous Sampling in Endocrine Dx
5/22
Technique
Seldinger Technique via the Femoral Veinfollowed by selective catheterization of the
relevant veins
Selective Arterial Catheterization in Arterialstimulation combined with Venous sampling
Blood Samples collected and Hormonal levels
are biochemically analyzed in each of the veins
selectively catheterized.
-
8/22/2019 Venous Sampling in Endocrine Dx
6/22
PRIMARY ALDOSTERONISM Xterized by the overproduction of the
mineralocorticoidhormonealdosterone by the
adrenal glands.
Aldosterone causes increase in sodium and
water retention and potassium excretion in the
kidneys, leading to arterial hypertension &
usually hypokalemia
Symptoms: Muscle cramps, Headache and
Muscle weakness.
http://en.wikipedia.org/wiki/Mineralocorticoidhttp://en.wikipedia.org/wiki/Hormonehttp://en.wikipedia.org/wiki/Aldosteronehttp://en.wikipedia.org/wiki/Adrenal_glandhttp://en.wikipedia.org/wiki/Sodiumhttp://en.wikipedia.org/wiki/Potassiumhttp://en.wikipedia.org/wiki/Kidneyhttp://en.wikipedia.org/wiki/Arterial_hypertensionhttp://en.wikipedia.org/wiki/Arterial_hypertensionhttp://en.wikipedia.org/wiki/Kidneyhttp://en.wikipedia.org/wiki/Potassiumhttp://en.wikipedia.org/wiki/Sodiumhttp://en.wikipedia.org/wiki/Adrenal_glandhttp://en.wikipedia.org/wiki/Aldosteronehttp://en.wikipedia.org/wiki/Hormonehttp://en.wikipedia.org/wiki/Mineralocorticoid -
8/22/2019 Venous Sampling in Endocrine Dx
7/22
Types
Adrenal Adenoma (Conn's Syndrome) (66%)
Bilateral idiopathic adrenal hyperplasia (30%)
Primary (unilateral) adrenal hyperplasia2% ofcases
Aldosterone-producing adrenocortical carcinoma
-
8/22/2019 Venous Sampling in Endocrine Dx
8/22
Diagnostic Screening
First Test
Simple blood tests that measure the levels ofpotassium, aldosterone, and renin (HighA ldos terone, Low Renin & Low Potassiumis Diagno st ic)
Second Test
Plasma aldosterone concentration (PAC) to
Plasma renin activity (PRA) ratio (PAC:PRA) -A high rat io is Diagnos t ic
Confirmatory Test
Captopril Suppression Test High
A ldos terone and Low Renin is Diagnos t ic .
http://endocrinediseases.org/adrenal/hyperaldosteronism_diagnosis.shtmlhttp://endocrinediseases.org/adrenal/hyperaldosteronism_diagnosis.shtml -
8/22/2019 Venous Sampling in Endocrine Dx
9/22
Diganosis and Treatment Algorithm for Primary Hyperaldosteronism
Screening test:
-
8/22/2019 Venous Sampling in Endocrine Dx
10/22
Etiological Diagnosis
Determination of the etiology of primary
aldosteronism remains a diagnostic challenge.
MRI or CT imaging is not a reliable method to
differentiate primary aldosteronism
AVS is more specific than anatomical imaging
modalities.
AVS was considered the gold standard in
determining the specific subtype of primary
aldosteronism
-
8/22/2019 Venous Sampling in Endocrine Dx
11/22
ADRENAL VENOUS SAMPLING[AVS]
IndicationsAVS is a direct assessment of hormonal
secretion
Detection of excessive aldosterone excretion
(Conn's syndrome)
Differentiation ofBilateral hyperplasia,
Aldosterone-secreting adenoma, and
Primary adrenal hyperplasiaUsed as Guide to Therapeutic Management
-
8/22/2019 Venous Sampling in Endocrine Dx
12/22
AVS - TECHNIQUE
EQUIPMENT
Angiography tray
5-Fr access sheath
5-Fr cobra-2 Catheter 5-Fr Hilal HS1 spinal, RDC or
sidewinder catheter
Small hole punch Nonionic contrast medium (25-50
mL)
-
8/22/2019 Venous Sampling in Endocrine Dx
13/22
AVS - TECHNIQUE
AVS - via the femoral vein
approach
Blood samples obtained
from IVC, Right and Left
adrenal vein. Samples for
Aldosterone, Cortisol,
and Epinephrine
concentrations wereobtained from all three
sites.
Cortrosyn given
during AVS.
Successful AVS
was determined by
at least a 3-foldelevation in
adrenal vein
Epinephrine and
Cortisol levelscompared with the
IVC.
-
8/22/2019 Venous Sampling in Endocrine Dx
14/22
AVS - TECHNIQUENormalized Aldosterone
Each Aldosteroneconcentration sample
was divided by the
Cortisol concentration
Dominant Gland the
larger sized gland
Non-Dominant - the
smaller sized gland
COMPLICATIONS
Adrenal vein damage
Spasm - result in
failure of the
procedure or ruptureof the vein.
Infarction of the gland
and loss of function
-
8/22/2019 Venous Sampling in Endocrine Dx
15/22
AVS - INTERPRETATION
APA and PAH Diagnosis
Ratio ofDom inant toNon-dominant
normal ized
aldosteronewould be4 or greater
Non-dominantnormal ized
aldosteronewould beless than or equal tothe Normal izedaldo sterone in the
IVC.
BAH - Diagnosis Aldosterone in each
adrenal vein wasequal to or greater
than the normalizedaldosterone from theIVC.
-
8/22/2019 Venous Sampling in Endocrine Dx
16/22
Arteriography and Arterial Stimulation with
Venous Sampling (ASVS) for Localizing
Pancreatic Endocrine Tumors
Pancreatic endocrine tumors are uncommontumors that belong to the family of APUDneoplasm.
1. Functional hormone -Associated withclinical syndrome
Gastrinomas (20%) Ulcerative (Zollinger)
Insulinomas (50%) - hypoglycemia
2. Nonfunctional - if not associated with clinicalsymptoms.
Pancreatic polypeptide secreting tumors
-
8/22/2019 Venous Sampling in Endocrine Dx
17/22
Role of ASVS in Insulinoma
Insulinomas are usually solitary
Distributed evenly throughout the pancreas5 -15% of insulinomas are malignant.
Preoperative workup with ASVS helps establishing
the diagnosis of insulinoma
Sensitivity of angiography in localizing insulinomas35% to 94%.
Sensitivity of calcium ASVS in localizing insulinomas
ranges from 78% to 100%.[
Insulinomas found at surgery are small: 90% lessthan 2 cm, 66% less than 1.5 cm, and 40% less than
1 cm.[2]
http://www.expertconsultbook.com/expertconsult/ob/linkTo?type=bookPage&isbn=978-1-4160-2964-9&eid=4-u1.0-B978-1-4160-2964-9..50117-4--bib21&appID=NGEhttp://www.expertconsultbook.com/expertconsult/ob/linkTo?type=bookPage&isbn=978-1-4160-2964-9&eid=4-u1.0-B978-1-4160-2964-9..50117-4--bib6&appID=NGEhttp://www.expertconsultbook.com/expertconsult/ob/linkTo?type=bookPage&isbn=978-1-4160-2964-9&eid=4-u1.0-B978-1-4160-2964-9..50117-4--bib6&appID=NGEhttp://www.expertconsultbook.com/expertconsult/ob/linkTo?type=bookPage&isbn=978-1-4160-2964-9&eid=4-u1.0-B978-1-4160-2964-9..50117-4--bib21&appID=NGE -
8/22/2019 Venous Sampling in Endocrine Dx
18/22
ASVS - INSULINOMA
Arterial stimulation and venous sampling(ASVS) is an important technique for localizing
insulinoma.
The principle behind ASVS is that insulinsecretion is promoted from insulinoma cells by
the injection of calcium into the insulinoma-
feeding artery
-
8/22/2019 Venous Sampling in Endocrine Dx
19/22
ASVS - TECHNIQUEIndications forCalcium ASVS
-Failure of non-invasive imaging to localize aninsulinoma.
-Regionalization of the insulinoma tumor whenmultiple tumors are present.
Contraindications Similar to diagnostic arteriography.
Relative contraindications include uncontrolledhypertension, uncorrectable coagulopathy ,
severe allergy to iodinated contrast, severerenal insufficiency, and congestive heartfailure.
For calcium ASVS, cardiac glycosides are a
relative contraindication.
-
8/22/2019 Venous Sampling in Endocrine Dx
20/22
ASVS - TECHNIQUEEQUIPMENT
4- or 5-Fr Simmons-1
catheter forHepaticVeins catheterization.
4-Fr cobra-2, SOS Omni,Simmons-1, and/or
Simmons-2 catheters forvisceral arteriography
0.027-inch inner diametermicrocatheters such asthe Renegade Hi-Flo allowa tighter bolus ofsecretagogue.
Nonionic iodinated agentsuch as iopamidol
SELDINGER APPROACH
B i lateral femo ral venous
approach, catheters areplaced into the right and lefthepatic veins.
Femoral arter ial approach,standard visceralarteriography is performed
Select ive inject ions of
con trast agent into m id
and prox imal splenic
artery in an attempt tolocalize a tumor to thepancreatic tail or body,respectively
-
8/22/2019 Venous Sampling in Endocrine Dx
21/22
Sampling Technique If a tumor blush is
visualized, the artery
supplying the blush is
injected with the
secretagogue last & 10%calcium gluconate.
Then 5-mL samples from
the hepatic veins are
obtained before and 20,
40, and 60 seconds after
calcium injection forbaseline Insulin levels
-
8/22/2019 Venous Sampling in Endocrine Dx
22/22
Conclusion
Visceral arteriography together with
arterial stimulation with venous sampling
(ASVS) has a high sensitivity in localizing
gastrinomas and insulinomas independentof their size.